CDTI invests, together with Asabys and AdBio Partners, in Orikine Bio

by CDTI Innovación

Orikine Bio develops therapies capable of 'reprogramming' the immune system, similar to how software engineers rewrite faulty code to repair computer systems.

Read more

CDTI invests in Integra Therapeutics, together with Invivo, Columbus, and AdBio Partners

by CDTI Innovación

Innvierte SICC of CDTI Innovación invests in Integra Therapeutics, together with three co-investors, to develop a gene-editing platform for the treatment of oncological, autoimmune, and genetic disea...

Read more

ARTHEx Biotech Upsizes Series B Financing Round to $87 millones

by Columbus Venture Partners

The Series B extension financing was led by Bpifrance and joined by all existing shareholders, including AdBio Partners, CDTI Innovación, Columbus Venture Partners, European Innovation Council (EIC),...

Read more

Integra Therapeutics, backed by Columbus and Invivo, to receive up to €10.5 million from European Commission for its FiCAT advanced therapies platform

by Columbus Venture Partners

Integra Therapeutics, a global leader in creating cutting-edge gene writing tools to make advanced therapies safer and more effective, will receive a grant of €2.5 million and equity investment of u...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream